METHAMPHETAMINE-DEPENDENCE
Clinical trials for METHAMPHETAMINE-DEPENDENCE explained in plain language.
Never miss a new study
Get alerted when new METHAMPHETAMINE-DEPENDENCE trials appear
Sign up with your email to follow new studies for METHAMPHETAMINE-DEPENDENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cash for clean tests: new app rewards drug abstinence
Disease control Recruiting nowThis study tests two ways of giving rewards to encourage people with opioid or cocaine use disorder to stay drug-free. 600 adults will use a smartphone app that tracks drug tests and offers incentives that either increase or decrease over time. The goal is to see which approach h…
Matched conditions: METHAMPHETAMINE-DEPENDENCE
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 17, 2026 04:15 UTC
-
New combo therapy aims to curb meth use in canadian trial
Disease control Recruiting nowThis study tests whether adding a high-dose stimulant medication and/or a reward-based program (contingency management) to standard care helps people reduce how often they use methamphetamine. About 440 adults with moderate to severe methamphetamine use disorder will be randomly …
Matched conditions: METHAMPHETAMINE-DEPENDENCE
Phase: PHASE2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug combo shows promise in meth addiction battle
Disease control Recruiting nowThis study tests whether a combination of two medications (extended-release naltrexone and bupropion) can help people with moderate to severe methamphetamine use disorder reduce their drug use. The study will enroll 360 adults who want to stop or cut down on meth. Participants wi…
Matched conditions: METHAMPHETAMINE-DEPENDENCE
Phase: PHASE3 • Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Can High-Dose stimulants help people quit meth? new trial aims to find out
Disease control Recruiting nowThis study tests whether giving a high-dose prescription stimulant (lisdexamfetamine) for 25 weeks helps people with moderate to severe methamphetamine use disorder stay in treatment and reduce use. About 80 adults who completed a prior trial will receive either the drug or a pla…
Matched conditions: METHAMPHETAMINE-DEPENDENCE
Phase: PHASE2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated May 11, 2026 20:51 UTC